Sewastianik T, Guerrera ML, Adler K, et al. Human MYD88^L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells. Blood Adv. 2019;3(21):3360-3374.

On p. 3371, in Figure 6A, the bottom representative image of Case #6 was inadvertently a duplicate of the middle image. The corrected Figure 6A is shown below.

Figure 6.

Implications of MYD88^L265P murine model for human LPL/WM. (A) MYD88 expression in plasmacytoid lymphocytes in BM biopsies from LPL/WM patients without (n = 11) and with (n = 13) MYD88^L265P mutation as evaluated by IHC staining. Three representative examples per each group are shown. Note punctate cytoplasmic staining of the MYD88^L265P, but not WT, protein. Scale bars, 5 μm. T-cell infiltration of BM biopsies from LPL/WM patients without (n = 13) and with (n = 13) the MYD88^L265P mutation.